CD14 and neoplasm: The CD14+ myeloid population (putative M-MDSCs) was also increased in tumor-bearing dogs (0.20% [0.06, 0.57]) when compared to healthy control dogs (0.14% [0.05, 0.24]; p = 0.018) but not those with inflammatory disease (0.28% [0.12, 0.64]; p = 0.72) (Supplementary Fig. S1C).